» Articles » PMID: 35096658

Sialidase Activity in the Cervicovaginal Fluid Is Associated With Changes in Bacterial Components of -Deprived Microbiota

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Sialidase activity in the cervicovaginal fluid (CVF) is associated with microscopic findings of bacterial vaginosis (BV). Sequencing of bacterial 16S rRNA gene in vaginal samples has revealed that the majority of microscopic BV cases fit into vaginal community-state type IV (CST IV), which was recently named "molecular-BV." Bacterial vaginosis-associated bacterial species, such as spp., may act as sources of CVF sialidases. These hydrolases lead to impairment of local immunity and enable bacterial adhesion to epithelial and biofilm formation. However, the impact of CVL sialidase on microbiota components and diversity remains unknown.

Objective: To assess if CVF sialidase activity is associated with changes in bacterial components of CST IV.

Methods: One hundred forty women were cross-sectionally enrolled. The presence of molecular-BV (CST IV) was assessed by V3-V4 16S rRNA sequencing (Illumina). Fluorometric assays were performed using 2-(4-methylumbelliferyl)-α-D-N-acetylneuraminic acid (MUAN) for measuring sialidase activity in CVF samples. Linear discriminant analysis effect size (LEfSe) was performed to identify the differently enriched bacterial taxa in molecular-BV according to the status of CVF sialidase activity.

Results: Forty-four participants (31.4%) had molecular-BV, of which 30 (68.2%) had sialidase activity at detectable levels. A total of 24 bacterial taxa were enriched in the presence of sialidase activity, while just two taxa were enriched in sialidase-negative samples.

Conclusion: Sialidase activity in molecular-BV is associated with changes in bacterial components of the local microbiome. This association should be further investigated, since it may result in diminished local defenses against pathogens.

Citing Articles

are major contributors of sialidases in the human vaginal microbiome.

Pelayo P, Hussain F, Werlang C, Wu C, Woolston B, Xiang C Proc Natl Acad Sci U S A. 2024; 121(36):e2400341121.

PMID: 39186657 PMC: 11388281. DOI: 10.1073/pnas.2400341121.


The Role of Species in Female Genital Tract Infections.

George S, Van Gerwen O, Dong C, Sousa L, Cerca N, Elnaggar J Pathogens. 2024; 13(5).

PMID: 38787215 PMC: 11123741. DOI: 10.3390/pathogens13050364.


The role of sialidases in the pathogenesis of bacterial vaginosis and their use as a promising pharmacological target in bacterial vaginosis.

Chen L, Li J, Xiao B Front Cell Infect Microbiol. 2024; 14:1367233.

PMID: 38495652 PMC: 10940449. DOI: 10.3389/fcimb.2024.1367233.


Human papillomavirus associated cervical lesion: pathogenesis and therapeutic interventions.

Ye J, Zheng L, He Y, Qi X MedComm (2020). 2023; 4(5):e368.

PMID: 37719443 PMC: 10501338. DOI: 10.1002/mco2.368.


Cervicovaginal Gardnerella sialidase-encoding gene in persistent human papillomavirus infection.

Novak J, Belleti R, da Silva Pinto G, do Nascimento Bolpetti A, Silva M, Marconi C Sci Rep. 2023; 13(1):14266.

PMID: 37652960 PMC: 10471596. DOI: 10.1038/s41598-023-41469-8.


References
1.
Castro J, Machado D, Cerca N . Unveiling the role of Gardnerella vaginalis in polymicrobial Bacterial Vaginosis biofilms: the impact of other vaginal pathogens living as neighbors. ISME J. 2019; 13(5):1306-1317. PMC: 6474217. DOI: 10.1038/s41396-018-0337-0. View

2.
Gajer P, Brotman R, Bai G, Sakamoto J, Schutte U, Zhong X . Temporal dynamics of the human vaginal microbiota. Sci Transl Med. 2012; 4(132):132ra52. PMC: 3722878. DOI: 10.1126/scitranslmed.3003605. View

3.
Briselden A, Moncla B, Stevens C, Hillier S . Sialidases (neuraminidases) in bacterial vaginosis and bacterial vaginosis-associated microflora. J Clin Microbiol. 1992; 30(3):663-6. PMC: 265128. DOI: 10.1128/jcm.30.3.663-666.1992. View

4.
Marconi C, Duarte M, Silva D, G Silva M . Prevalence of and risk factors for bacterial vaginosis among women of reproductive age attending cervical screening in southeastern Brazil. Int J Gynaecol Obstet. 2015; 131(2):137-41. DOI: 10.1016/j.ijgo.2015.05.016. View

5.
Hillier S, Lau R . Vaginal microflora in postmenopausal women who have not received estrogen replacement therapy. Clin Infect Dis. 1997; 25 Suppl 2:S123-6. DOI: 10.1086/516221. View